Zobrazeno 1 - 10
of 115
pro vyhledávání: '"LAWRENCE R. SOMA"'
Autor:
Lawrence R, Soma, Darko, Stefonovski, Mary A, Robinson, Deborah S, Tsang, Joanne, Haughan, Ray C, Boston
Publikováno v:
American Journal of Veterinary Research. :1-9
OBJECTIVE A retrospective study was conducted to establish the prerace venous acid-base and blood gas values of Standardbred horses at rest using big data analytics. SAMPLES Venous blood samples (73,382) were collected during seven racing seasons fro
Autor:
Joanne E. Haughan, Jaclyn R. Missanelli, Youwen You, Darko Stefanovski, Lawrence R. Soma, Mary A. Robinson
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 45:273-282
Glaucine, an aporphine alkaloid with anti-tussive, anti-inflammatory, and anti-nociceptive properties, has been identified in post-race samples from racehorses. To investigate pharmacokinetics of glaucine in horses, a three-way crossover study of int
Autor:
Lawrence R. Soma, Darko Stefanovski, Joanne Haughan, Jinwen Chen, Zibin Jiang, Mary A Robinson
Publikováno v:
Drug Testing and Analysis. 14:973-982
Extracorporeal shockwave therapy (ESWT) is a treatment applied to musculoskeletal injuries in equine athletes to alleviate pain and accelerate healing. ESWT also causes acute tissue damage. Therefore, its ability to act as an analgesic and cause tiss
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 44:349-358
Capsaicinoids deter horses from chewing on bandages and are applied topically to provide analgesia to musculoskeletal injuries. They are banned during competition due to their nerve blocking properties. The pharmacokinetics of oral (PO) and direct ga
Publikováno v:
Journal of Veterinary Pharmacology and Therapeutics. 41:825-837
Intravenous (iv), subcutaneous (sq), and topical (tp) lidocaine was administered to six horses in a cross-over, randomized design study. Samples were collected for up to 72 hr. Compartmental models were used to investigate the pharmacokinetics of (LD
Publikováno v:
Journal of Veterinary Emergency and Critical Care. 27:539-547
Objective Evaluate the analgesic properties and pharmacokinetics of transdermal fentanyl patches (TFPs) in goats. Design Prospective, randomized study. Setting Preclinical Testing Facility at a University Teaching Hospital. Animals Thirty-four adult
Autor:
Xiaoqing Li, Lawrence R. Soma, Cornelius E Uboh, Fuyu Guan, Fengchang Zhu, Youwen You, George A Maylin, Ying Liu
Publikováno v:
Journal of Analytical Toxicology. 41:431-440
A rapid and sensitive method for simultaneous screening, quantification and confirmation of 17 barbiturates in horse plasma using liquid chromatography-tandem mass spectrometry is described. Analytes were recovered from plasma by liquid-liquid extrac
Pharmacokinetics of xylazine after 2-, 4-, and 6-hr durations of continuous rate infusions in horses
Autor:
Raymond C. Boston, Bernd Driessen, Klaus Hopster, Lawrence R. Soma, Charlotte Hopster-Iversen, Xiaoqing Li
Publikováno v:
Hopster, K, Soma, L R, Li, X, Hopster-Iversen, C, Boston, R C & Driessen, B 2020, ' Pharmacokinetics of xylazine after 2-, 4-, and 6-hr durations of continuous rate infusions in horses ', Journal of Veterinary Pharmacology and Therapeutics, vol. 43, no. 6, pp. 557-564 . https://doi.org/10.1111/jvp.12873
Intravenous (i.v.) bolus administration of xylazine (XYL) (0.5 mg/kg) immediately followed by a continuous rate infusion (CRI) of 1 mg kg-1 hr-1 for 2, 4, and 6 hr produced immediate sedation, which lasted throughout the duration of the CRI. Heart ra
Autor:
Mary A Robinson, Lawrence R. Soma, Jinwen Chen, Darko Stefanovski, Joanne Haughan, Raymond C. Boston, Zibin Jiang
Publikováno v:
Equine veterinary journalReferences. 52(3)
BACKGROUND: Extracorporeal shockwave therapy (ESWT) can potentially mask painful injuries in equine athletes. Tests to detect whether a horse has received ESWT prior to competition are needed. Extracorporeal shockwave therapy is known to affect infla
Publikováno v:
Drug Testing and Analysis. 9:1421-1431
Etanercept is a protein-based medication for the treatment of human patients with rheumatoid arthritis and other autoimmune-based diseases; its pharmacological action is to inhibit and antagonize tumour necrosis factor alpha. Etanercept was rumoured